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INTRODUCTION
Cervical cancer is the second most common malignant 
disease among women worldwide with nearly 80% 
of cases occurring in less developed countries (1). 
About 500,000 new cases are diagnosed annually 
(2). Cervical cancer accounts for the death of 231,000 
women annually with over 80% of these deaths 
occurring in developing countries. In Ghana, a study 
done over a 52 month period in Korle-Bu Teaching 
Hospital (KBTH) showed cervical cancer to account 
for 58.3% of gynaecological cancers (3). Studies in 
Ivory Coast and Gambia have revealed cervical 
cancer incidences of 24 and 34% respectively (4,5). 
Number of sexual partners, smoking, age of first 
sexual contact and immunological status have been 
identified as significant risk factors for development 
of cervical cancer (6,7). 
 Human papillomaviruses have been identified 
as the central etiologic agents of cervical cancer (8). 
It is also clear from several case control and cohort 
studies that HPV infection is the main factor for the 
development of cervical intraepithelial neoplasia 
(CIN) and that risk is significantly increased by 
persistent infection with high risk HPV genotypes 
such as types 16 and 18 (9-12). More than 200 types of 
HPV have been identified using DNA sequence data, 
out of which 40 different types have been detected 
in the anogenital area (13). Based on their oncogenic 
potential, genital HPVs have been divided into 
high and low risk. High-risk types such as HPV 16, 
18,31,33,35,39,45,51,52,56,58,66 and 68 are associated 
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ABSTRACT
Background: Human papilloma viruses (HPV s) have been considered to be the necessary 
and central agents of cervical cancer among women with nearly 80% of cases found 
in developing countries. 
Objective: To determine HPV genotypes prevalent in Ghanaian women with cervical 
cancer. 
Design: Retrospective study. 
Setting: Pathology Department, University of Ghana Medical School, College of Health 
Sciences, University of Ghana. 
Subjects: Ghanaian women 23 to 80 years diagnosed with cervical cancer. 
Results: Of the 50 samples genotyped, 49 (98%) were determined as positive for HPV 
DNA. Eight out of 18 different HPV genotypes were detected and all were high-risk 
types. In decreasing order of prevalence, were HPV 18 in 42 (84%) samples, HPV 16 
in 12 (24%) samples, HPV 45 in three (6%) samples, HPV 39 in two (4%) samples and 
HPV 35, 52,56 and 66 in one (2%) sample each. Multiple infections were detected in 
13 (26%) of the 50 samples, the most common co-infections being HPV types 16/18 
(18%). Triple infections were found in two (4%) samples with HPV types 16, 18 and 39. 
HPV type 18 was more relatively frequent in adenocarcinomas and adenosquamous 
carcinomas than in squamous cell carcinomas. 
Conclusion: Eight high-risk HPV genotypes: 16, 18, 35, 39, 45, 52, 56 and 66 were typed, 
with HPV type 18 being the most prevalent in Ghanaian women with cervical cancer. 
This is contrary to the worldwide prevalence where HPV 16 is the most common type 
associated with invasive cervical carcinoma. 
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with high grade CIN and invasive cervical cancer 
(13). Other genotypes such as HPVs 6, 11, 34, 40, 42, 
43 and 44 are classified as low risk types, detected in 
benign lesions such as condyloma accuminata (14). 
 Detection of high-risk HPV infections helps 
to identify women who are at increased risk of 
development or the progression of a cervical lesion 
(15, 16). Several HPV targeted therapies and vaccines 
have been developed, however, it would be better to 
know the HPV genotypes that are prevalent in each 
geographical region of the world so that type specific 
or globally effective vaccines can be produced. A 
previous study in Ghana showed a 10.7% prevalence 
of HPV in Ghanaian women attending gynaecological 
clinics (17). In this present study we determined the 
prevailing genotypes of HPV present in Ghanaian 
women with cervical cancer. 
MATERIALS AND METHODS
Tissue Materials and Histological Analysis: Formalin-
fixed paraffin embedded blocks of 50 patients with 
histologically proven cervical cancer obtained from 
archival specimens of the Pathology Department, 
Korle-Bu Teaching Hospital, Accra, between January 
and December 2003 were used in this study. Ethical 
approval to use the samples was granted according 
to ethical guidelines established in the University 
of Ghana Medical School. The first and last sections 
(5µm) of each tissue were stained with haematoxylin 
and eosin. These were used as microscopic controls 
to ensure that the tissue sections used in the PCR 
contained malignant tissue. To avoid carried-over 
contamination from one block to another during 
sectioning, a new disposable microtome knife was 
used to cut sections from each block. 
Preparation of Genomic DNA: Genomic DNA was 
prepared using the method described by Dabic et al. 
(18) with slight modifications. Briefly, 10µm section 
was cut from each paraffin block into a 2.0ml micro-
centrifuge tube. These sections were incubated in 
250µl lysis buffer, [lmg/ml Proteinase K (Sigma, 
USA), in 50mM Tris-HCL pH 8, ImM EDTA, and 
0.5% Tween-20 (Sigma, USA)] for 16 hours at 56°C. 
Proteinase K was inactivated at 100°C for five minutes 
and the lysate centrifuged at 13000 rpm for five 
minutes. 0.2-2µ1 of the supernatant was then used 
for PCR amplification and the rest of the DNA lysate 
stored at -20°C until further use. 
 HPV Nested Multiplex PCR: Primer sets 
(Eurogenetics, Belgium) and the method described 
by Sotlar et al. (19) was used. The HPV genome was 
amplified using consensus forward primer (GP-E6-3F) 
and two consensus back primers (GP-E7 -5B and GP-
E7-6B). The PCR reaction mix of 50µ1 contained 10x 
PCR, buffer (Promega, USA), 2.5mM MgC2, 200µM of 
each of the four oligonucleotide triphospates (dNTPs) 
(Promega, USA), 15pmols of each E6/E7 consensus 
primer and 1.25 units of Taq Polymerase enzyme 
(Promega, USA). 0.2-2µ1 of DNA lysate was used as 
template for the amplification reaction and sterile 
double distilled water used to make up the volume to 
50µ1. The DNA amplification was carried out using a 
Techne thermal cycler (Progene , Princeton, NJ, USA). 
The cycling parameters for the first round PCR with 
the E6/E7 consensus primers were as follows: 94°C 
for four minutes followed by 40 cycles of 94°C for one 
minute, 40°C for two minutes, 72°C for two minutes 
and a single final elongation step of 72°C for ten 
minutes. For each reaction positive controls (HPV 16 
and 18 plasmid DNA) and a negative control (double 
distilled water) were included. In the second round 
nested PCR. 1µl of first round PCR product, 15pmols 
of forward and reverse primers for genotyping were 
used. The other parameters above remained the 
same. The genotyping cycling parameters were as 
follows: 94°C for four minutes followed by 35 cycles 
of 94°C for 30seconds. 56°C for 30 seconds, 72°C for 
45 seconds and a single final elongation step of 72°C 
for four minutes. 
 Primers for the identification of high-risk 
genotypes: 16,18,31,33,35,39,45, 51, 52, 56, 58, 59, 66 
and 68 and low-risk genotypes 6/11, 42, 43 and 44 
were used. The primers were used in four cocktails 
each containing four to rive different primer pairs. 
The PCR products were run on a 2% agarose gel and 
stained with 0.5µg1ml ethidium bromide to detect 
the presence of amplified DNA fragments with a 
hundred base pair DNA molecular weight marker 
was run along side. 
RESULTS
The mean age of HPV positive patients was 54.1 years 
(S.D = 7.6years) ranging from 23 to 80 years. The 
oldest case was a squamous cell carcinoma and the 
youngest, an adenocarcinoma (Table 1). All samples 
were positive for HPV DNA. Forty nine (98%) of the 
50 samples could not  be typed based on the primers 
used. In one case a squamous cell carcinoma, we 
could determine the genotype. Table 2 shows all the 
HPV genotypes identified, multiple infections were 
counted more than once. A total of eight different 
HPV genotypes of the 18 possible genotypes were 
detected and all were high risk types. One HPV 
positive sample did not genotype with any of the 
primers used. HPV 18 was the most prevalent as 
this was found in 42 (84%) of the 50 samples. The 
prevalence of other genotypes was as follows: HPV 
16 in 12 (24%) samples. HPV 45 in three (6%) samples. 
HPV 39 in two (4%) samples. and HPV 35,52,56 and 
66 in one (2%) sample each. 
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Table 1
Age Distribution of Types of Cancers in Genotyped 
Samples
Age  SCC  ADC/ASC Total
20-29  0  1  1 
30-39  4  1  5 
40-49  10  3  13 
50-59  12  3 13 
60-69  6  1 7 
70-79  6  1 7 
80-89  1  0 1 
Total  39  10  49 
Key: 
SCC: Squamous cell carcinoma 
ADC: Adenocarcinomas 
ASC: Adenosquamous carcinomas 
Table 2
HPV Genotypes in Relation to Histologic Types
Hpv Genotypes  Histologic Type  Relative 
  Frequency 
 Squamous cell Adenocarcinomas Adenosquamous 
 carcinomas carcinomas carcinomas 
HPV-16  11  1  0 18.8% 
HPV-18  32  7  3 65.6% 
HPV-35  1  0 0 1.6% 
HPV-39  2  0 0 3.1% 
HPV-45  3  0 0 4.7% 
HPV-52  1  0 0 1.6% 
HPV-56  1  0 0 1.6% 
HPV-66  1  0 0 1.6% 
HPV-X1  1  0 0 1.6% 
1Untypable sample based on the 18 primers used for genotyping though positive for HPV DNA
 Thirteen (26%) of the 50 specimens had multiple 
infections of which 11 were double infections with 
HPV types 16 and 18 in nine and one each with 
16 and 35 and 18 and 45. Two samples had triple 
infections with HPV 16, 18 and 39. Thirty-nine of the 
HPV positive samples were squamous carcinomas, 
eight were adenocarcinomas and three were 
adenosquamous carcinomas. HPV 18 was present 
relatively more frequently in tumours with glandular 
component (10 out of 11) than in pure squamous cell 
carcinomas whereas HPV 16 was detected relatively 
more frequently in squamous cell carcinomas (11 of 
39) than adenocarcinomas (1 of 11). 
DISCUSSION
The diagnosis of HPV infection in recent times has 
been based on the detection of viral DNA using PCR 
assays (10,15). In this work a nested multiplex PCR 
developed by Sotlar et al. (19) was used in the detection 
and genotyping of HPV types in paraffin embedded 
cervical carcinomas in Ghanaian women. 
 Many epidemiological studies indicate that 
human cancer develops through different molecular 
biologic pathways. Currently, there is compelling 
evidence that the development of human cervical 
cancer without the involvement of specific HPV 
is exceptional or impossible (15). HPV DNA has 
been found to be in 46.9 to 100% of archival cervical 
carcinoma specimens using PCR based methods 
(16). In this study, HPV DNA prevalence was 98%, 
which was comparable with other studies (15,16,18). 
These studies detected HPV in between 65 to 87.6% 
of patients with invasive cervical cancer in formalin 
fixed and paraffin-embedded tumour tissues using 
PCR analysis. To our knowledge, this study is the 
first genotyping of cervical carcinomas using paraffin 
embedded specimens in Ghana. 
 A total of 85 studies using PCR to estimate HPV 
prevalence in invasive cervical cancer in different 
parts of the world revealed that the common HPV 
types, in order of decreasing prevalence were 16, 
18,45,31,33,58,52,35,59,56,6,51,68,39, 82, 73, 66 and 80 
(2). In these studies, for squamous carcinomas (SCC), 
HPV 16 was the predominant type followed by HPV 
18, 45, 31 and 33 in all regions except Asia, where 
HPV types 58 and 52 were more frequently identified. 
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Also for adenocarcinoma (ADC) and adenosquamous 
carcinoma (ASC), HPV prevalence was significantly 
lower than in SCC and HPV 18 was the predominant 
type in every region, followed by 16 and 45 (10). The 
international biological study on cervical cancer also 
reported HPV 16 as the most prevalent type in 22 
countries with the exception of Indonesia, where 
HPV 18 was the most prevalent type (10). However, 
in this work the most prevalent HPV type was HPV 
18, followed by 16,45 and 39 respectively. 
 Data collected from several studies had shown 
that HPV 31 and 33 were frequently found in 
cervical carcinomas (10) but these genotypes were 
absent in the 50 samples we used. This probably 
supports suggestion that there are different types 
of HPV causing cancers in different parts of the 
world. In these samples we genotyped, no low risk 
HPV types were detected in any of HPV positive 
samples obtained supporting the fact that only high 
risk HPVs are integrated into the host cell genome 
(20). This present study strengthens the argument 
of causal association between adenocarcinoma/
adenosquamous carcinomas and HPV 18 (8). Three 
cases of HPV 45 were detected which agreed with 
some clusters of HPV 45 previously found in West 
Africa (10). 
 Multiple infections were present in about 12.8% 
of the cervical cancer samples used in this work. 
Recent studies also indicated that the presence of 
multiple HPV infections might contribute to the 
development or progression of cervical dysplasia 
(21). The complex interaction of concomitant HPV 
infections in cervical carcinogenesis remains to be 
investigated in the future. 
In conclusion, this study provides data about the 
HPV genotypes associated with cervical cancer in 
Ghanaian women. Eight high-risk HPV genotypes: 
16, 18,35,39,45,52,56 and 66 were detected and this 
supported the fact that only high risk HPV’s are 
integrated into the host cell chromosome in cervical 
carcinogenesis. HPV type 18 was the most common 
HPV genotype associated with cervical cancer in 
Ghanaian women for the samples genotyped. 
 We believe that this paper provides baseline 
information on current prevalence of high risk HPV 
types in cervical cancer in Ghanaian women and this 
will serve as the basis for comparison of all future 
studies on the subject. 
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